42387 Rar BEST

The adjuvant formulation work was funded in part by the Bill and Melinda Gates Foundation grants 42387, OPP1055855, and OPP1130379, and by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Human and Health Services under grant 5R21AI109118 and contract HHSN272200800045C. We gratefully acknowledge Susan Lin, Sarah Parker, Sandra Sivanantha, Traci Mikasa, Tiep Pham, and Molly Blust for excellent technical assistance.

42387 rar

041b061a72